Rhythm Eyes Bigger Market For Imcivree Following Phase II Hypothalamic Obesity Promise

 
• By Ayisha Sharma

The US firm’s Imcivree has impressed with interim mid-stage data from a hypothalamic obesity study, paving the way for pivotal success that could open up a much larger market.  

Children With Hypothalamic Obesity Experience A False Sense Of Uncontrollable Hunger • Source: Shutterstock

More from Clinical Trials

More from R&D